Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nikolai Tz. Tzvetkov"'
Autor:
Doroteya K. Todorieva, Nikolai Tz. Tzvetkov, Vanya S. Popova, Ivailo G. Hristov, Kalina K. Ignatova, Lachezar H. Bogdanov, Pencho T. Tonchev, Dobromir D. Nguen
Summary Chronic lymphocytic leukemia is one of the most common types of leukemia affecting adults over 65 years of age [1]. The disease is a part of the so-called indolent lymphomas and has a variable clinical course, defined by many factors. In rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b003bca5cc14775196e8d7b4cce67f42
Autor:
Ralitza G. Ilieva, Petranka G. Chumpalova-Tumbeva, Vanya S. Popova, Nikolai Tz. Tzvetkov, Doroteya K. Todorieva-Todorova, Georgi K. Georgiev, Aleksandar A. Todorov, Ljudmil Z. Tumbev, Adelaida L. Ruseva, Ivailo G. Hristov, Niya A. Krasteva, Emiliya M. Dimitrova, M. Stoimenova-Popova, Valentin I. Valtchev
Publikováno v:
Journal of Biomedical and Clinical Research. 10:140-145
Summary Affective disorders, including depression, are of great social importance and lead to serious everyday life infringement and disability. Affective disorders are one of the main causes of suicide causes. Anxiety disorders represent a variety o
Autor:
Zhanet Grudeva-Popova, D. Tumbeva, G. Tzvetkova, Emil Spasov, B. Spasov, P. Ganeva, L. Gercheva, R. Petrova, I. Micheva, Nikolai Tz. Tzvetkov, Lachezar H. Bogdanov, E. Hadzhiev, Vesselina Goranova-Marinova, K. Ignatova, G. Arnaudov, A. Radinov
Publikováno v:
Annals of Oncology. 30:v437-v438
Background Brentuximab Vedotin (BV) treatment has improved the prognosis and survival of patients with Hodgkin’s lymphoma, relapsed after stem cell transplantation or having refractory disease. Aim: To analyze the prognostic factors, influencing th
Autor:
Vasil Todorov, Vanya Slavcheva, Nikolai Tz. Tzvetkov, Stanislava Panayotova, Kalina K. Ignatova
Publikováno v:
Journal of IMAB, Vol 21, Iss 2, Pp 767-769 (2015)
767 SUMMARY: Acute lymphoblastic leukemia is a disease, which is more common in children. We report a clinical case of a patient aged 25. Thirty-two months before his last admission in Hematology clinic, acute pre- B lymphoblastic leukemia had been d